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Social anxiety disorder, also known as social phobia, is one of the most prevalent anxiety disorders, affecting 7-13% of 
subjects in the community at some time in their Jives. Despite being eminently treatable, it remains largely under-recognised 
and, therefore, undertreated. The disorder is characterized by a fear of scrutiny by others, with sufferers experiencing 
excessive anxiety in social and performance situations. This excessive anxiety usually leads to avoidance behaviour that can 
severely affect normal daily living. With onset commonly occurring during childhood or adolescence, social anxiety disorder 
may disrupt normal patterns of development of social and personal relationships, often having a long-term impact on emo­
tional stabiIity in social or working life. Ir left untreated, the course of social anxiety disorder is frequently compIicated with 
comorbid conditions, particularly major depression or substance abuse. This reviewassesses the size of the clinical problem 
by evaluating current and lifetime prevalence estimates, age of onset, risk factors and evolution of the clinical course; thereby 
providing the rationale for early recognition and prompt treatment. Int Clin Psychopharmacol 1S (suppt 1):S7-S12 © 2000 Lippincott 
WiIliams & Wilkins 
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INTRODUCTION 
Anxiety in stressful social situations is, generally 
speaking, anormal and even ubiquitous human re­
sponse to challenging situations and a certain level of 
distress and anxiety is even necessary for individuals 
to develop and to function normally. However, such 
anxiety reactions, in terms of their frequency and the 
degree of anxiety symptoms related to it, may become 
exaggerated to the point of interfering with normal 
functioning. Sodal anxiety disorder (social phobia) is 
characterized by persistent, umeasonably strong, fre­
quently overwhelming fears of sodal and performance 
situations where individuals are fearful of being scru­
tinized by other people and being subject to negative 
evaluation. 
In social anxiety disorder, the fear can occur in vir­
tually all types of everyday situations involving sodal 
interactions. such as speaking with others or attending 
a meeting or a party, and also in special situations, such 
as taking a test or examination and public speaking. 
In same sufferers, the disorder can be confined to a 
small circumscribed set of situations. In others, it can 
occur in a wide variety of social situations; in these 
cases, a diagnosis of 'generalized sodal anxiety dis­
order' is assigned. When antidpating or experiencing 
exposure to a provo king situation, the sufferer will al­
most invariably have an anxiety reaction, which may 
take the form of a panic attack. The distress caused by 
the anxiety almost always leads to pronounced and per­
sistent avoidance of the situation; this sense of distress 
and the subsequent avoidant behaviour usually signifi­
cantly limits the individual's social development, for 
example with regard to social relationships, thereby re­
stricting social life and achievements in both educa­
tion and at work. 
This review ex amines some of the more recent evi­
dence focusing on descriptive and causal analytic epi­
demiological studies of social anxiety disorder, in terms 
of its prevalence, clinical evolution and assodated com­
plications. Additionally, the burden of the disorder on 
medical services is assessed to demonstrate how early 
recognition and treatment could both reduce healthcare 
utilization and minimize the individual's suffering. 
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PREVALENCE 
In the past 10 years, numerous studies have investigated 
the frequency of strictly-defined sodal anxiety disorder 
in various parts of the world by means of large-scale 
representative sampIes of the general population 
(Kessler et al., 1994; Lin et al., 1996; Wittchen et al., 
1998; Lecrubier et al., 2000; Heimberg et al., 2000) 
and, less frequently, in primary care (Weiller et al., 
1996). Whether using DSM-IV or DSM-Ill-R criteria 
the l-year and lifetime prevalence rates of this condi~ 
tion have demonstrated it to be a common anxiety dis­
order in all populations assessed. In the United States, 
for example, the National Comorbidity Survey (NCS) 
(Kessler et al., 1994) evaluated the l-year and lifetime 
prevalences as 8 and 13%, respectively; in Canada, the 
Ontario Health Survey (Lin et al., 1996) reported 7 and 
13%, respectively; and in Europe, the Early Develop­
mental Stages of Psychopathology Study (EDSP) 
(Wittchen et al., 1998) in 14- to 24-year-olds reported 
5 ~nd 10%, respectively. In primary-care offices, 
Weiller et al. (1996) reported a current prevalenee 
estimate of 5-7% and, as part of this intern~tional 
WHO study, further highlighted that while this disor­
der is eommon, it is rarely correetly diagnosed at the 
primary care level; in the main, patients were diagnosed 
as psyehological cases, but not necessarily as suff er­
ing from sodal anxiety disorder. 
Few data are yet available about the prevalenee of 
the generalized subtype of social anxiety disorder, 
which is eonsidered to be a more severe form seen fre­
quently in specialist settings according to most elini­
eal studies (Heimberg et al., 1990; Mannuzza et al., 
1995; Stein et al, 1998). In the EDSP study (Wittehen 
et al., 1998), longitudinal data showed that although 
both subtypes had a eomparable eurrent prevalenee (3.6 
nongeneralized versus 3.0 generalized), the eumulative 
lifetime likelihood of experiencing nongeneralized 
sodal anxiety disorder was notieeably higher (6.4 
nongeneralized versus 3.9 generalized). Data from this 
study support the view that there is a greater persist­
ence of the more severe, generalized form of sodal 
~xiety disorder, while the nongeneralized subtype re­
nuts spontaneously more frequently (Müller, 2000). 
ONSET 
~nlike agoraphobia, panie disorder, generalized anxiety 
dIsorder, and depressive disorder, social anxiety disorder 
almost always has an early onset, in ehildhood or ado­
lescence (BeideI, 1998). Consistently across a11 epide­
miological studies only a few eases have been identi­
fied that reported an onset of the condition after the 
age of 21 years. Even in those with a later onset of the 
fuH disorder, in most cases significant signs of the dis­
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order have ~een e~ident .in early life. Given the early 
onset of SOCIal anxIety disorder. it is noteworthy from 
a differential diagnostie perspective that aceording to 
DSM-IV stipulations, it is not reeommended to sum­
mari~e th~ disorder under the 'avoidant type' of per­
sonallty dIsorders. As social anxiety disorder is a more 
specific condition for which established treatment 
exists, and given that personality dis order should not 
include signifieant clinical syndromes of the axis I 
disorders, preference should be given to the diagnosis 
of social anxiety disorder rather than to a personality 
disorder. 
From an aetiological perspective, the early onset of 
social anxiety disorder points to the significance of 
potential genetie and familiallinks as weIl as tempera­
mental variations as signifieant contributors to the onset 
of this condition. Furthermore, it should be highlighted 
that although phobie dis orders during ehildhood and 
adolescenee are frequently a transient developmental 
phenomenon, (e.g. in the case of animal, darkness and 
separation phobias that oecur at certain ages more or 
less clearly in the development of the majority of chil­
dren ~or some time but then spontaneously remit at 
least In early puberty), the fear of social interaction is 
a comparatively more stable phenomenon (Aehenbach 
1985; Beidei, 1998) and is more likely to persist both 
in chiIdhood and during adolescence into adulthood. 
RISK FACTORS 
There are numerous and quite unique factors that have 
been associated with an increased risk for first onset 
of social anxiety dis order and its persistence both from 
clinical as weIl as epidemiologieal studies' (Wittchen 
et al:,. 1999a; Lieb et al., 2000; Magee et al., 1996). 
Farmlial and developmental factors are of special im­
portanee, in that they exist before the onset of the dis­
order, and thus might be most informative in terms of 
the underlying vulnerabilities. 
Several studies have demonstrated that social anxi­
ety disorder runs in farnilies, with both farnilial genetic 
and environmental contributions. Twin studies in 
females suggest concordance of24.4% between mono­
zygotic twins and 15.3% between dizygotic twins. In 
addition to twin studies, other types of farnily studies 
also provide support for familial aggregations (Bei deI, 
19~8; Fyer, 1993). These studies were performed in 
p~tIen: sampies, but further evidenee was recently pro­
vIded I? a study of a community sampIe of 1053 par­
ents (LIeb et al., 2000) that prospectively examined the 
5-year risk of their offspring developing social anxi­
ety disorder during adolescenee. Three groups of par­
en~ were identified.: (1) parents with no lifetime diag­
nosIs of amental dIsorder; (2) parents with a lifetime 
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diagnosis of amental dis order, for example, depres­
sive disorder, but not social anxiety disorder; (3) those 
who fulfilled the diagnostic criteria of social anxiety 
disorder. The children of the parents in the last group 
(3) were found to be much more likely to develop so­
ciaI anxiety disorder during adolescence, with an odds 
ratio (OR) of 4.7 (95% CI: 1.7-13.0). This study also 
confrrmed that, independent from this parental asso­
ciation, family environmental factors, specifically pa­
rental overprotection (OR: 1.4) and rejection (OR: 1.4), 
were additional risk factors for the onset of social anxi­
ety disorder, underlining significant links between fa­
milial genetic and environmental factors. 
Among other early antecedents of social anxiety 
disorder, behavioural inhibition (BI) was repeatedly 
confirmed as a strong contributory behavioural­
temperamental risk factor (Rosenbaum et al., 1993; 
Kagan, 1997; BeideI and Turner, 1997). BI refers to 
neurobiological and psychological constructs that de­
scribe the fear of the unfarniliar; this is defined as a 
tendency for children to react consistently to unfamil­
iar events with restrained withdrawal and shyness. As­
sessable even in young children by means of parent re­
ports and behavioural child observation, BI has been 
repeatedly shown to provide highly significant asso­
ciations with the development of social anxiety disor­
der in later life. Measuring these temperamental states 
in children shows that those with higher BI values are 
significantly more likely to develop social anxiety dis­
order than others (Kagan et al., 1988; Hayward et al., 
1998; Beidei, 1998; Lieb et al., 2000). Additionally, 
as high BI values in children have been associated with 
high BI values in parents, we can assume that tempera­
ment is a risk factor for the development of social anxi­
ety dis order. Müller (2000) recently confirmed this, in 
a large representative community sampie of 3021 ado­
lescents and young adults (OR: 4.5); however, whether 
this temperamental disposition is a necessary or suffi­
cient aetiological factor remains to be determined 
(Beidei and Turner, 1997). Furthermore, significant risk 
factors also suggested include trauma, separation 
events, and preceding phobias (Stemberger et al., 1995; 
Müller, 2000). With regard to sociodemographic fac­
tors that may also influence the onset of social anxiety 
disorder, it is so far not known to what degree these 
factors are consequences or correlates of the dis order. 
Poor financial situation (OR: 1.7), low social class 
(OR: 3.1), never being married (OR: 2.1), unemploy­
ment (OR: 2.3), and poor education (OR: 3.1) fre­
quently relate to lack of socialization during the early 
stages of the disorder. In addition, factors such as age 
below 21 years (OR: 6.1), and fe male sex (OR: 1.9) are 
direct correlates of social anxiety disorder (Magee et 
al. , 1996; Müller, 2000). 
Symptoms 
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Figure 1. Evolution of social anxiety disorder. 
Evolution, clinical course and comorbidity 
Beyond numerous in-depth clinical studies of smaller 
sampIes, the evolution of social anxiety dis order has 
recently been followed by the EDSP study of 3021 
community cases (Wittchen et al., 1998). The major­
ity of cases of social anxiety disorder have emerged by 
the time an individual has reached their early 20s, when 
either a progressive worsening or a persistent course 
will have been established. Many individuals, espe­
cially in late adolescence, will also report a waxing 
and waning course (Wittchen et al., 1999a), whereby 
social problems can be temporarily ameliorated by vir­
tue of their attachment to a particular partner in a calm­
ing relationship, but then a new challenge in life will 
precipitate the re-presentation of the full disorder 
(Müller, 2000) (Fig. 1). The main outcome of the EDSP 
study suggests that irrespective of some variations in 
severity (fluctuation between symptomatic, subthresh­
old and threshold stages), considerably fewer individu­
als with sodal anxiety disorder will have a stable and 
spontaneous remission; with the exception of specific 
childhood phobias, the remission rate in sodal anxi­
ety disorder is the lowest amongst all anxiety disor­
ders (Wittchen et al., 1999a). It is noteworthy however, 
that the EDSP study was also unable to identify what 
specific events actually provoke the onset of the dis­
order (see Fig. 1). Behavioural theories of aetiologies 
suggest three potential mechanisms: direct condition­
ing, in which fear develops from exposure to a critical 
ortraurnatic event; vicarious leaming (observation sig­
nals in a traumatic situation); and information trans­
fer, by the verbal or non-verbal transmission of infor­
mation about sodal situations. Reasons both for and 
against these perspectives are possible, however as in 
earlier studies, the retrospective nature of the assess­
ments prevents frrm conc1usions from being drawn. 
The evolutionary model described above suggests 
that in certain individuals there is a vulnerability, such 
that when confronted with achallenging or critical situ­
ation they are more likely to develop enduring social 
fear and subsequent avoidance. This can lead to a 
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restriction in their lifestyle, and prevent them from 
making the most of available opportunities. These 
individuals can develop disabilities in their school, 
work, and social life, with particular problems in the 
initiation and maintenance of relationships with the 
opposite sex. Sufferers may experience demoralization 
and even full blown depressive disorder, and develop 
inadequate coping behaviours; for exampIe, using 
alcohol or nicotine in order to alleviate their suffer­
ing. Over time, increased disability and a reduced qual­
ity of life could be expected in such individuals, as weIl 
as increasing rates of comorbidity with secondary men­
tal disorders. 
Some of these hypotheses have been examined in 
several studies, one of which was a retrospective analy­
sis of the NCS (Kessler et al., 1999). The findings dem­
onstrated a high prevalence of comorbidity, with many 
individuals suffering from social anxiety disorder also 
meeting the diagnostic criteria for major depression or 
dysthymia. Specifically, it showed that the probability 
for a comorbid mental disorder was approximately 
50%. With regard to the course of comorbidity, social 
anxiety disorder was generally the primary condition 
with major depression and dysthymia being second­
ary disorders. 
There are recognized !imitations of a retrospective 
analysis. However, a more recent prospective study 
demonstrates similar findings (EDSP data: Wittchen et 
al., 1999a). In this study, adolescents and young adults 
with social anxiety disorder, of the generalized or 
nongeneralized subtype, but without any significant 
depressive symptoms, were assessed over aperiod of 
several years, and the prospective occurrence of depres­
sive episodes was monitored. It was found that indi­
viduals with sodal anxiety disorder were 3.5 times 
more likely to develop a major depressive episode than 
those with no sodal anxiety disorder; furthermore, the 
risk for secondary depressive disorders was slightly 
higher in generalized as opposed to nongeneralized 
social anxiety disorder. It was noteworthy that subjects 
with sodal anxiety disorder aiready comorbid with 
depression were at a further and greatly increased risk 
of either having no remission of depression, or experi­
endng a new episode of depression (OR: 8.7). This 
suggests that social anxiety disorder is not only a risk 
factor for depression, but is also associated with a more 
malignant course and character of subsequent depres­
sive illness (Fig. 2). 
The EDSP survey also examined the probability that 
individuals with sodal anxiety disorder have an 
increased risk for developing substance abuse disor­
der. This was verified, and it was found that sufferers 
have an increased intake of, and dependence on, legal 
substances such as alcohol (OR: 1.8) (Fig. 2). The 
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Figure 2. Risk of developing comorbid disorders. 
individuals were also more Iikely to develop nicotine 
dependence (Sonntag et al., 2000). Abuse of, or de­
pendence on, illegal drugs was Iess likely to occur, 
probably due to the subjects being anxious about break­
ing the law. Individuals with sodal anxiety disorder 
also manifested symptoms associated with other anxi­
ety disorders and in some cases the symptomatology 
was sufficient to meet the diagnostic criteria for an­
other anxiety disorder (Fig. 2). 
Demoralization as a resuit of enduring sodal anxi­
ety disorder can precipitate suicidal ideation and may 
lead to suicide attempts. This was investigated in a 
community sampie, where individuals with social anxi­
ety disorder, both in its pure form and in the comorbid 
condition, were compared with controls (Wunderlich 
et al., 1998). It was found that, although subjects with 
the pure form were much more likely to 'feellike want­
ing to die' and 'feIt so low that they had suicidal idea­
tion', the rate of suidde attempts did not differ from 
that in the control group. In individuals with comorbid 
depression however, the risk of suicide attempts was 
greatly increased (Table 1). Thus the comorbid picture 
of social anxiety disorder plus major depression rep­
resents a particularly high risk group for suicidal idea­
tion and suicide attempts. 
In summary, patients with sodal anxiety disorder are 
at an increased risk ofdeveloping secondary depressive 
episodes, and social anxiety disorder can be consid­
ered a risk factor for depression. Furthermore, the 
depression is likely to develop at an earlier age than in 
a matched control group, and secondary depression is 
more persistent than a pure depressive disorder. These 
patients are also more likely to develop substance abuse 
and dependence. 
Disability and quality of life 
Functional disability and quality of life assessment has 
been used as a more generic measure of individual suf­
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Table 1. Suicidal behaviour in social anxiety disorder 
(Wunderlich et al., 1998) 
Controls Pure Comorbid 
('Yo) ('Yo) (~) 
Suicide attempts 0.2 0.9 15.7 
Thought a lot about death 11.3 26.8 53.8 
Feit like you wanted to die 4.2 8.9 27.7 
Feit so low you wanted to 2.1 9.8 37.3 
commit suicide 
fering (Davidson et aZ., 1994; Magee et aZ., 1996). The 
degree of functional impainnent in various sodal roles 
(e.g. days unable to work, reduced work performance 
and impaired sodal interaction) has been assessed 
using the Liebowitz Sodal Disability Scale (LSDS) or 
the CIDI Disability Module (CDM), and the extent to 
which an individual's health impacts on their day-to­
day functioning and enjoyment of life has been assessed 
using the Medical Outcomes Study Short Form 36 (SF­
36), Quality Of Life Inventory (QOLI) and the lllness 
Intrusiveness Ratings Scale (llRS). 
Using a control group comprised of individuals with 
another socially-embarrassing disorder, herpes infec­
tion, reduction in work productivity was measured us­
ing the Work Productivity and Activity Index (wpAI) 
score (Wittchen et aZ., 1999b). When compared with 
the controls (1.5%), a significantly greater reduction 
in work productivity (P < 0.001) was demonstrated by 
both the individuals with pure social anxiety disorder 
(11.4%) and those with comorbid depressive symptoms 
(12.4%). 
Assessing quality oflife, using SF-36, both pure and 
comorbid patients were compared with the control 
group and with depressed outpatients (Wittchen and 
Beloch, 1996; Wittchen et aZ., 1999b). Patients with 
comorbid social anxiety disorder exhibited quality of 
life irnpairment similar to depressed outpatients (mark­
edly, 31.4% vs. 28.7%; severely, 51.0% vs. 31.4%). 
However, a surprising finding was that a sirnilar pat­
tern also occurred in those patients with pure social 
anxiety disorder (24.6 and 23.1 %, respectively). 
More detailed analyses of quality of life impairment 
have demonstrated an increased risk of leaving school 
early (OR: 1.72), disability in major social roIes 
(OR: 4.15) and marked dissatisfaetion with friends 
(OR: 5.19), leisure activities (OR: 2.37) and ineome 
(OR: 1.87) (Stein et al., 1999). Additionally, long-term 
findings have shown that sodal anxiety disorder is 
associated with increased likelihood of being unem­
ployed (OR: 2.8), lower educational attainment in 
terms of university and professional training (OR: 4.2) 
and inereased probability of being single or divorced 
(OR: 2.8) (Wittchen et al., 1999a). 
The impact of this reduced quality of life and 
increased functional dis ability on healtheare utilization 
was assessed by the Dean Foundation Study (D. J. 
Katzelnick, presented at meeting of the American Psy­
chiatric Assoeiation, 1999, New Orleans, USA). Using 
a large managed care population of 10 000 people, the 
study found that current costs associated with social 
anxiety dis order, compared with matched controls, rep­
resented a significantly higher (P =0.04) health-eco­
nomic burden (approximately $2400 versus approxi­
mately $1900). 
Usage of medical services has remained remarkably 
stable over the years, with utilization in the 1980s being 
similar to that reported in 1992 (Schneier et al., 1992). 
Pure sodal anxiety disorder does not ineur high utili­
zation rates per se and patients tend to receive little 
psychiatric or general outpatient treatment, unless the 
sodal anxiety disorder beeomes complicated by 
another dis order. 
SUMMARY AND CONCLUSIONS 
Sodal anxiety dis order is a common condition, with 
current prevalence estimates in the range of 5-7% and 
a lifetime risk of7-13%. It has an earl y onset and, with­
out appropriate intervention, it has a disproportionately 
higher risk of persistenee, compared with other anxi­
ety disorders. Presentation differs between age groups, 
the disorder in teenagers and in those in their early 20s 
tending to look different in terms of types of problem 
and the associated distress, to that expected in the 30s 
and 40s age groups, when the individual has already 
endured 20 years of suffering and disability. There is 
an increased risk of depression and substance abuse 
dis orders even in adolescenee, in addition to an 
inereased risk of psychosodal impairment and disabil­
ity resembling that experienced by depressed out­
patients. This is particularly true in cases affected by 
generalized sodal anxiety disorder, which might have 
slightly different aetiological pathways than the non­
generalized type. 
Individuals who develop comorbid conditions have 
a more severe level of disability. Early recognition, 
diagnosis and treatment of social anxiety dis order could 
minimize suffere;rs' problems throughout their subse­
quent lives, preventing the development of comorbidity 
and a worsened prognosis. Developing models for early 
recognition and treatment should improve outeome for 
the patient, as weH as redudng future demand on 
healthcare resources. 
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